Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Pharmacology and Pharmacotherapy Angiotensin-Renin-Bradykinin System HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by